-
ACHEMA - WORLD FORUM AND 34th LEADING INTERNATIONAL TRADE FAIR, JUNE 10th-14th, 2024
This year, a team of Valicare experts will also be present at Achema. You are welcome to visit us at this fascinating event. Further details and information on the registration form can be found here. >>>
-
APV SEMINAR, MAY 14th-15th, 2024
The seminar will cover biopharma stability and cold stability for biologics/therapeutic proteins, with topics such as mechanisms of freezing, control of freezing & thawing, modelling, equipment, stabilisation by excipients, R&D strategies and alternative methods.
Further information and the registration form can be found here. >>>
-
CHAMPALIMAUD FOUNDATION:TIL-WORKSHOP, APRIL 24th-25th, 2024
Visit the Champalimaud TIL workshop (Tumor Infiltrating Lymphocytes) for the treatment of patients with solid cancers. For more information click here >>>
-
ATMP BLOCK LECTURE, APRIL 12th, 2024
vOnline introduction to the pharmaceutical requirements for the manufacture and testing of ATMPs. Register in good time, there are only 30 external places available. Click here to register >>>
-
GMP PHARMA CONGRESS, MARCH 20th, 2024
As a part of the GMP Pharma Congress, you can look forward to an exciting presentation by our Senior GMP Project Manager Dr Carsten Börger in collaboration with Frank Hesseler from Schlafender Hase. The topic of the presentation is the ,,Development and validation of a cloud-based system for automated text verification''. Information and registration form can be found here. >>>
-
DG-GT ANNUAL MEETING, MARCH 6th-8th, 2024
The DG-GT e.V. brings together scientists and clinicians who are involved in the most diverse areas of vector development, gene transfer techniques, gene therapy treatment strategies and their implementation in the clinic. More information can be found here >>>
-
CULT.TAINER WEB SESSION, JANUARY 30th, 2024
In this webinar, we will introduce the cult.tainer® concept, a turnkey production solution for GMP-compliant iATMPs. For further details and the registration formular, click here. >>>
-
VIRTUAL LECTURES GMP-BASICS I-III, NOVEMBER 3 & 4 & 24, 2023
The lecture by Dr. Hans-Georg Eckert, Managing Director and Senior Consultant of Valicare GmbH, will take place as part of the Master's Course MSc Bioanalytical Chemistry and Pharmaceutical Analysis at Fresenius University in Idstein. The three virtual training modules will be offered free of charge via Zoom. For further details and the access link, please click here. >>>
-
ISPE-ATMP SEMINAR, NOVEMBER 20 & 21, 2023
An ISPE DACH ATMP seminar focusing on aseptic processing technologies in the pharmaceutical industry. The event will include a tour of the Robert Bosch Hospital. More details about the event can be found on the linked website. >>>
-
7TH CELL THERAPY SYMPOSIUM, NOVEMBER 3 & 4, 2023
We are excited to be part of this year's 6th Cell Therapy Symposium at Heidelberg University Hospital. This symposium serves as a platform for the latest advancements in cell therapy.
>>>
Welcome to Valicare!
ATMP news from around the world
Our international press review contains a selection of news and recent articles on advanced therapy medicinal products (ATMPs), chimeric antigen receptor T-cell therapy (CAR), tumor infiltrating lymphocytes (TILs) and bioengineered tissue products (TEPs).
New FDA Draft Guidance Made Available for Materials Used in Manufacturing CGTs and Tissue-Engineered Therapeutics
04.05.2024 | Pharmaceutical TechnologyA new draft guidance issued by FDA covers human- and animal-derived materials used in the manufacture of advanced therapy medicinal ...
Neu entdeckter Mechanismus der T-Zell-Kontrolle kann Krebs-Immuntherapien beeinträchtigen
03.05.2024 | German Cancer Research CenterTragen aktivierte T-Zellen ein bestimmtes Markerprotein auf ihrer Oberfläche, so werden sie von natürlichen ...
Neuer immuntherapeutischer Ansatz für das seltene, aber sehr aggressive Nebennierenrindenkarzinom
03.05.2024 | Onkologie HeuteROR1-spezifische CAR-T Zellen zeigen starke Antitumor-Wirksamkeit bei fortgeschrittenem adrenokortikalen Karzinom. Für dieses ...
Evaluating, Validating, And Implementing NAT-Based Mycoplasma Detection Methods
03.05.2024 | BioProcess OnlineBy BioPhorum Implementing alternative methods for adventitious agents can slash >90% of testing time and realize cost savings of up to $5 ...
Labcorp’s Companion Diagnostic Assay for Beqvez Receives FDA Approval
03.05.2024 | CGTLiveTesting for the presence of neutralizing antibodies is an essential step before patients can receive Beqvez.
Direct in vivo CAR T cell engineering
02.05.2024 | ScienceDirectAuthor links open overlay panelLauralie Short 1 2, Robert A. Holt 1 2 3 4, Pieter R. Cullis 5, Laura Evgin 1 2 3 ...
Turning a tumor's 'shield' into a weapon against itself
02.05.2024 | Medical XpressTumor cells are "cunning," according to Peter Yingxiao Wang. They have a nefarious way of evading the human immune responses that fight ...
Around the Helix: Cell and Gene Therapy Company Updates – May 1, 2024
01.05.2024 | CGTLiveCatch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.
Manufacturing Capacity Expansion and Validation for Autologous Cell Therapies
01.05.2024 | Parenteral Drug Association... by Stephan Krause, PhD and Adam Boyer, Myers Squibb ...
April 2024: FDA's Landmark Month for Cancer Treatment Innovations
01.05.2024 | Targeted OncologyHere are the latest FDA approvals, designations, and decisions from April 2024.
Cell Therapy Manufacturing: Time to Move Fast
30.04.2024 | American Biotech NewsEmily Whitehead made the history books in 2012 when she become the first pediatric patient with B-cell acute lymphoblastic leukemia to be ...
Analyzing the Potential Application of MSCs as a New Treatment of Pulmonary Fibrosis and ARDS
29.04.2024 | Physician's WeeklyThe following is a summary of “Potential application of mesenchymal stromal cells as a new therapeutic approach in acute respiratory ...
Bauchspeicheldrüsen-Tumore aus dem Labor: Organoide helfen, die Krebsentstehung zu verstehen
26.04.2024 | Science-Online.org... 28.04.2021 19:06 Für die Krebsforschung haben Ulmer Wissenschaftlerinnen und Wissenschaftler Bauchspeicheldrüsen-Organoide ...
Mesenchymal stem cells and their derived exosomes for the treatment of COVID-19
26.04.2024 | NewswiseNewswise — Coronavirus disease 2019 (COVID-19) is an acute respiratory infection caused by severe acute respiratory syndrome coronavirus 2 ...
Cell & Gene Therapies: FDA Regulatory Implications For 2024
20.04.2024 | Pharma AdvancementThe fact is that most in the biotech industry know that cell and gene therapies- CGT are regulated across the U.S. as biological products ...
Valicare – competent, reliable & efficient
You have little time and still want to know what services Valicare GmbH offers?